Granata Bio

Curated by Signal

Developer of therapeutics for women's health and infertility

Overview

Developer of therapeutics for women's health and infertility. It offers pipeline of drug candidates which include Ganirelix Acetate Injection. Milophene for ovulation induction, Progesterone for luteal phase support, and GB-hMG for infertility treatment.

Key facts

Founded: 2018
Headquarters: Duxbury, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

5 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Mimic Technologies
Develops simulation training equipment for the Da Vinci surgical robotic systems
Life Sciences TechnologySeattle, United States
Cofactor Genomics
Developer of diagnostic assays using RNA sequencing
Life Sciences TechnologySan Francisco, United States
Neoclease
Provider of precision gene editing solutions throug synthetic biology and AI algorithms for advancing genomic medicine
Life Sciences TechnologyBoston, United States

About Granata Bio

What does Granata Bio do?

Developer of therapeutics for women's health and infertility.

Where is Granata Bio headquartered?

Granata Bio is headquartered in Duxbury, United States.

When was Granata Bio founded?

Granata Bio was founded in 2018.

Which sector is Granata Bio in?

Granata Bio operates in Life Sciences Technology.

Who are Granata Bio's competitors?

Companies similar to Granata Bio include Mimic Technologies, Cofactor Genomics, and Neoclease.